11th February 2016, 7pm
Französische Friedrichstadtkirche, Gendarmenmarkt 5, 10117 Berlin
The event will be held in english.
Medicine gets personal - gene-based therapies for a new era in treatment?
Panel discussion with internationally renowned scientists including Nobel Laureate Bruce Beutler and Einstein Visiting Fellow Hans Schreiber
Research in the field of “personalised medicine“ inspires high hopes. Its aim is to provide customized therapies for patients based on their individual genetic code. Diseases such as cancer, diabetes or cardiovascular disorders could be detected earlier, more effectively and with fewer side effects. In the long term, the goal is to prevent these diseases from developing in the first place. But how exactly does this approach work? What lessons have been learned so far? What are the the prospects? What are the constraints? In an open dialogue with internationally renowned scientists, Einstein Visiting Fellow Hans Schreiber will discuss the main challenges of personal or “precision“ medicine, as it is often called.
Immunologist and geneticist, University of Texas Southwestern, Nobel Laureate in Physiology or Medicine 2011
Professor of Personalized Medicine at Charité - Universitätsmedizin Berlin, Chairman of the Berlin Institute of Health
Director of the Institute of Pathology at Charité - Universitätsmedizin Berlin, Vice-Chairman Berlin Cancer Society
Director of the Department of Paediatrics at Charité – Universitätsmedizin Berlin, Einstein Professorin
Professor for Systems Biology, Max Delbrück Center for Molecular Medicine
Einstein Visiting Fellow
The discussion will be moderated by Christiane Löll, science journalist and author.
Einstein Visiting Fellowship
The event takes place as a part of the Einstein Visiting Fellowships of Hans Schreiber. The professor of pathology is one of the most renowned experts in the fight against cancer. After completing his studies in Freiburg he continued his career in the US, where he taught at the University of California at Berkeley. As chairman of the Committee for Immunology at the University of Chicago Schreiber developed a new laser scanning method that makes it possible for the first time to observe tissue of cancer cells on a living organism. This provides valuable insights on the functioning of individual cancer cells.
These research findings will now also be applied in Berlin. Through the Einstein Foundation's funding Schreiber can build a local research team and finance its extensive experiments. The cooperation of the Charité-Universitätsmedizin with the University of Chicago and the research of Hans Schreiber could lead to a breakthrough in the fight against cancer.
Please be advised that photos and video footage will be taken during the event and used for editorial and promotional purposes of the Einstein Foundation. By participating you agree to their publication.